Partner Organizations Signed to Present HopeLink's Syndicated Network Include ALCASE, Cancer Research Foundation of America, Colorectal Cancer Network, Healthcommunities.com, International Myeloma Foundation, National Brain Tumor Foundation, National Multiple Sclerosis Society, National Prostate Cancer Coalition, Oncology Nursing Society, The Breast Cancer Fund, US TOO! and 0thers
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-14-2001/0001492366&EDATE=
MENLO PARK, Calif.,
May 14 /PRNewswire/ -- HopeLink Corporation today announced that more than
20 organizations including healthcare companies, non-profit organizations,
patient advocacy groups, research cooperatives, and voluntary health societies
have partnered with HopeLink to offer its groundbreaking clinical trial
service to cancer patients and their advocates. HopeLink is building a
syndicated network and Clinical Trial Service that are designed to improve
the clinical trial development and enrollment processes. HopeLink's service
has been available since December 2000 and currently lists oncology trials.
The company expects to offer clinical trials in other disease states in
the future.
"The quality, breadth
and enthusiasm of our syndicated network partners endorses our approach
to facilitating clinical trial awareness worldwide," said Jim Messemer,
president and CEO, HopeLink. "When people are diagnosed with cancer,
many turn to Internet search engines to quickly locate websites that have
disease specific information. Our syndicated network is specifically
designed to provide critical clinical trial information to the websites
patients and their advocates are visiting most often."
The more than 20
organizations that will be presenting HopeLink's Clinical Trial Service
on their websites include: Alliance for Lung Cancer Advocacy, Support
and Education (ALCASE); American Foundation for Urologic Disease; American-Italian
Cancer Foundation; Annie Appleseed Project; Cancer Research Foundation
of America; Cherubim Foundation; Colorectal Cancer Network; Florida Cancer
Education Network; Healthcommunities.com's OncologyChannel.com; HealthFrontier.com;
HealthLinks.net; International Myeloma Foundation; Kidney Cancer Association;
Lung Cancer Online; Lustgarten Foundation for Pancreatic Cancer Research;
National Brain Tumor Foundation; National Breast Cancer Coalition; National
Multiple Sclerosis Society; National Prostate Cancer Coalition; Oncology
Nursing Society; The Breast Cancer Fund; and US TOO! To view the
live Clinical Trial Service on HopeLink's syndicated network, visit the
following url: http://www.hopelink.com/about_service/find
The HopeLink Clinical
Trial Service is a free, accessible and searchable directory of clinical
trials that instantly provides patients, advocates, research professionals
and healthcare organizations with the latest information on drug therapies
under development, including enrollment information and eligibility requirements.
HopeLink also offers its customers and partners a number of workflow, reporting
and content management tools to facilitate clinical trial participation.
"HopeLink's service
allows us to provide patients with easy access to clinical trials," said
Rob Tufel, MSW, MPH, and director of patient services, National Brain Tumor
Foundation. "Patients are now able to find all the information they
need through our website without having to sort through the often overwhelming
amount of information on the Internet."
"We are excited
to incorporate HopeLink's services on OncologyChannel.com as it provides
a much needed resource for patients and their families to instantly learn
about the latest clinical trials," said Dr. Stanley J. Swierzewski III,
founder and CEO, Healthcommunities.com. "Having as much information
as possible about diagnosis and treatment options is very important to
our audience. Our partnership with HopeLink helps us meet our goal
of providing trustworthy medical information online."
"HopeLink's service
has become one of the most used areas on our website," said Mike Katz,
vice president, International Myeloma Foundation. "Useful and accurate
information saves lives and HopeLink is helping us provide this information
to myeloma patients around the world."
HopeLink does not
recruit or enroll patients in clinical trials, accept advertising revenue,
or collect per-patient compensation or "bounties." The company leverages
its syndicated network of partner websites to help patients and their advocates
self-select for clinical trials. HopeLink's customers include industry
sponsors and investigative sites that pay service fees in exchange for
enhanced clinical trial listings and process management tools.
"We believe that
a self-referral model that empowers individuals will emerge as a major
channel for patient enrollment in addition to the current flow from physician
referrals," said Larry Hausner, vice president of strategic partnerships,
HopeLink. "Our unique partnership strategy allows HopeLink to have
enormous reach and touch millions of people seeking potentially lifesaving
treatment options."
"We selected HopeLink
as our partner because the company is patient-centered and has a policy
not to accept per-patient bounties or resell patient lists to investigators,"
said Priscilla Savary, executive director, Colorectal Cancer Network.
"HopeLink's service empowers our patients by allowing them to self-select
for a clinical trial and is especially appealing because it allows us to
offer this benefit with a minimal amount of effort on our part."
"HopeLink's search
capabilities are easy-to-use, fast, and accurate," said Elizabeth G. Gomez,
RN, MSN, AOCN, and editor of ONS Online, the official website of the Oncology
Nursing Society. "We selected the HopeLink Clinical Trial Service
because it enhanced our award-winning clinical trials content and we didn't
have to spend precious resources to build it ourselves."
"The National Prostate
Cancer Coalition is committed to ending the devastating impact prostate
cancer has on American men and their families. To realize our mission,
we must equip survivors and advocates across the country with the most
useful and effective tools," said Skip Lockwood, director of programs and
senior editor, National Prostate Cancer Coalition. "HopeLink's Clinical
Trial Service is just what we have been looking for to help patients and
families find potentially lifesaving treatments while advancing the research
needed to find a cure for cancer."
"As a cancer advocacy
group, one of the goals of the Cancer Research Foundation of America is
to educate the public about the value of clinical trials and help individuals
understand that trials are the only way to translate the amazing breakthroughs
made in laboratories around the country to new, more effective treatments
for patients," said Carolyn Aldige, President and Founder, Cancer Research
Foundation of America. "Our partnership with HopeLink brings us one
step closer to realizing this goal."
Organizations interested
in presenting HopeLink's Clinical Trial Service on their websites and becoming
a syndicated network partner can email info@hopelink.com. Clinical
trial sponsors interested in listing trials on HopeLink's service may also
email info@hopelink.com.
About the HopeLink
Clinical Trial Service
The HopeLink Clinical
Trial Service is a hosted, web-based application that facilitates patient
enrollment and creates process efficiencies for organizations that sponsor
and conduct clinical trials. This turnkey software solution, launched
in December 2000, can be tailored to ensure successful deployment and integration
of new and existing processes. The service is presented through a
syndicated network of numerous partner websites.
About HopeLink
Headquartered in
Menlo Park, CA, HopeLink is a privately held software company that provides
products and services to improve the clinical trial development and enrollment
processes. HopeLink's solutions aim to not only increase clinical
trial awareness and exposure, but also to create efficiencies through standardization
and automation of time-consuming processes. The company's investors
and management team are comprised of experienced executives from the healthcare,
high technology, and non-profit sectors. HopeLink can be reached
at http://www.hopelink.com .
SOURCE HopeLink Corporation
Web Site: http://www.hopelink.com/about_service/find
http://www.hopelink.com
.